People vaccinated against COVID-19 may be sick…See more ​‍͏

by

  • Long-term Data: Evidence shows sustained safety, though more research is needed for children,  cancer patients, and immunocompromised groups.

    • WHO Guidance (2026)

    • Routine Vaccination: Recommended for high-risk groups (elderly, immunocompromised, healthcare workers).
    • Coadministration:  COVID-19 vaccines can be safely given alongside influenza and other routine immunizations.
    • Future Research: Focus on durability of protection, variant-specific boosters, and equity in global distribution.

    Risks and Trade-offs

    • Breakthrough  Infections: Vaccinated individuals may still contract  COVID-19, especially with immune-evading variants.
    • Waning Immunity: Protection decreases over time, making boosters essential.
    • Global Inequity: Access to updated vaccines remains uneven, leaving vulnerable populations at risk.

      Conclusion

      COVID-19 vaccination continues to be one of the most effective  public health tools. While not perfect,  vaccines drastically reduce severe outcomes and remain safe across populations. The future lies in variant-adapted boosters, global equity, and ongoing research to refine strategies.

      « Previous Next »
      5
      Pages: 1 2 3 4

    Leave a Comment